Talking Medicines
Talking Medicines is a data intelligence company specializing in healthcare marketing. They offer AI-powered solutions like Drug-GPT to extract actionable insights from healthcare conversational data, helping healthcare agencies and pharmaceutical companies enhance their marketing strategies and improve patient outcomes. Their focus on advanced data science and AI positions them as a leader in the healthcare data intelligence sector.
Employees
28
Founded
2013
Ownership
other
Est. revenue
$3.2M
Headcount
28
Website visitors
48,120
Workforce
Headcount by location
- United Kingdom86%
- United States7.1%
- Spain7.1%
Split by department
- Engineering & R&D24%
- Founder, Owner & Executive14%
- Consulting & Advisory9.5%
- Customer Support9.5%
- Marketing & Comms4.8%
Seniority distribution
- Less than 5 years38%
- 5 to 10 years29%
- 10 to 20 years19%
- 20 to 30 years9.5%
- 30 years and more4.8%
Funding
$1.9M
Raised to date
DateTypeAmountInvestors
- 1 Feb 2022Convertible Note$1.9MEnteroBiotix, Scottish Enterprise, Tern PLC - we back growing IoT companies, The Scottish National Investment Bank
Investors
InvestorCompanies backedCountry
Scottish EnterpriseScottish Enterprise is a not-for-profit economic development agency that supports businesses in Scotland by providing strategic guidance, funding access, and market insights. It focuses on helping companies innovate and scale, particularly in749United Kingdom
The Scottish National Investment BankScottish National Investment Bank is a public entity that serves as a development investment bank focused on providing patient capital to businesses and projects in Scotland. It aims to deliver environmental, social, and financial returns122United Kingdom
Tern PLC - we back growing IoT companiesTern PLC is an investment company that focuses on empowering technology firms, particularly those involved in disruptive innovations and the Internet of Things. It provides investment and advisory services to help startups navigate market challenges8United Kingdom
EnteroBiotixEnteroBiotix is a biotechnology company specializing in microbiome therapeutics aimed at improving gut health. They develop innovative treatments for gastrointestinal disorders, focusing on products like EBX-102-02. Their customers include patients2United Kingdom
Revenue
$3.2M
EBITDA
24.8M
Revenue source: Modeled estimate
Recent news
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
In the app
The full Talking Medicines profile lives in Inven.
Get in touch
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.
Business Brokers
Investment Banking
Private Equity
M&A
Consulting
Venture Capital
Corporate Development
Search Funds
Business Brokers
Investment Banking
Private Equity
M&A
Consulting
Venture Capital
Corporate Development
Search Funds